Edges in Network
| Network | GSE18864_egf1520 - GSE18864 - SiGN-BN HC+Bootstrap |
| Network Description | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
| Node | SLC34A3 |
| Upstream (Parents) |
|---|
| (<<) RHOD → SLC34A3 |
| Downstream (Children) |
|---|
| SLC34A3 → ADRBK1 (>>) |
| SLC34A3 → B3GNT2 (>>) |
| SLC34A3 → BCAM (>>) |
| SLC34A3 → BCL2L1 (>>) |
| SLC34A3 → CASP10 (>>) |
| SLC34A3 → CAV3 (>>) |
| SLC34A3 → CD4 (>>) |
| SLC34A3 → CDH22 (>>) |
| SLC34A3 → CHST10 (>>) |
| SLC34A3 → DNM1L (>>) |
| SLC34A3 → E2F4 (>>) |
| SLC34A3 → EGF (>>) |
| SLC34A3 → EHD1 (>>) |
| SLC34A3 → FLJ35390 (>>) |
| SLC34A3 → FNDC4 (>>) |
| SLC34A3 → GNAI1 (>>) |
| SLC34A3 → GPR153 (>>) |
| SLC34A3 → GSK3A (>>) |
| SLC34A3 → HBEGF (>>) |
| SLC34A3 → HDAC11 (>>) |
| SLC34A3 → HDAC5 (>>) |
| SLC34A3 → HGS (>>) |
| SLC34A3 → HIPK1 (>>) |
| SLC34A3 → KLK3 (>>) |
| SLC34A3 → KRAS (>>) |
| SLC34A3 → LRCH4 (>>) |
| SLC34A3 → LYPLA2 (>>) |
| SLC34A3 → MAP3K11 (>>) |
| SLC34A3 → MAPK1 (>>) |
| SLC34A3 → MAPK11 (>>) |
| SLC34A3 → MAPK3 (>>) |
| SLC34A3 → MEF2A (>>) |
| SLC34A3 → MESDC1 (>>) |
| SLC34A3 → MLX (>>) |
| SLC34A3 → MMP14 (>>) |
| SLC34A3 → MMP28 (>>) |
| SLC34A3 → MPP1 (>>) |
| SLC34A3 → MUC2 (>>) |
| SLC34A3 → MVK (>>) |
| SLC34A3 → MYH14 (>>) |
| SLC34A3 → PIK3C3 (>>) |
| SLC34A3 → PLA2G4D (>>) |
| SLC34A3 → PRPF4B (>>) |
| SLC34A3 → PTPN12 (>>) |
| SLC34A3 → RAB5A (>>) |
| SLC34A3 → RCBTB1 (>>) |
| SLC34A3 → RCOR1 (>>) |
| SLC34A3 → RHOT2 (>>) |
| SLC34A3 → SEMA5B (>>) |
| SLC34A3 → SH3GL1 (>>) |
| SLC34A3 → SMTN (>>) |
| SLC34A3 → SPPL2B (>>) |
| SLC34A3 → SPRR1A (>>) |
| SLC34A3 → SPRR2G (>>) |
| SLC34A3 → SUFU (>>) |
| SLC34A3 → SULT2B1 (>>) |
| SLC34A3 → TAF1A (>>) |
| SLC34A3 → TARSL2 (>>) |
| SLC34A3 → TMEM154 (>>) |
| SLC34A3 → TRAF1 (>>) |
| SLC34A3 → UAP1 (>>) |
| SLC34A3 → UBE2D2 (>>) |
| SLC34A3 → UBE2D4 (>>) |
| SLC34A3 → UTS2R (>>) |
| SLC34A3 → WBP4 (>>) |
| SLC34A3 → WNT6 (>>) |
| SLC34A3 → ZFPM1 (>>) |
| SLC34A3 → ZNF579 (>>) |
